newdrugapprovals.org
FDA grants priority review to Pharmacyclics drug
ibrutinib FDA grants priority review to Pharmacyclics drug Pharmacyclics is getting a priority review of its blood cancer treatment by federal regulators. A priority review shortens a drug evaluati…